1. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies
   Yao Xiong et al, 2018, PLOS ONE CrossRef
2. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
   Qiang Zhou et al, 2021, Technology in Cancer Research & Treatment CrossRef
3. The correlation between hepatocellular carcinoma susceptibility and XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln – A meta-analysis
   Neha Merchant et al, 2023, Human Gene CrossRef
4. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis
   Ri-Chu Zhang et al, 2013, Tumor Biology CrossRef
5. New sights on the associations between the XRCC1 gene polymorphisms and hepatocellular carcinoma susceptibility
   Wenjuan Cai et al, 2020, Journal of Cellular Biochemistry CrossRef
6. DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis
   WENYAN LI et al, 2014, Oncology Letters CrossRef
7. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population
   Wafaa M. Radwan et al, 2015, Renal Failure CrossRef
8. The association of six non‐synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta‐analysis
   Yan‐Hui Shi et al, 2016, Journal of Cellular and Molecular Medicine CrossRef
9. XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC
   Zhihua Xiao et al, 2019, Cell & Bioscience CrossRef
10. XPD Functions as a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells
    Ji-xiang Zhang, 2015, Medical Science Monitor CrossRef
11. Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk
    Qiliu Peng et al, 2014, Medicine CrossRef